The UK‐PBC risk scores: Derivation and validation of a scoring system for long‐term prediction of end‐stage liver disease in primary biliary cholangitis
Marco Carbone(Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda), George Mells(Cambridge University Hospitals NHS Foundation Trust), Steve Flack(University of Cambridge), Michael A. Heneghan(King's College London), Mark Aldersley(St James's University Hospital), Carolyn Adgey(University of Ulster), Gideon M. Hirschfield(University Health Network), Paul Trembling(Barts Health NHS Trust), Andrew Bathgate(University of Cambridge), Kelly Spiess(University of Cambridge), Stephen J. Sharp(University of Cambridge), D. I. Jones(Indian Institute of Technology Madras), Andrew K. Burroughs(University College London), R.T. Lim(Queen Elizabeth Hospital Birmingham), Heather J. Cordell(Newcastle University), Kate D. Williamson(John Radcliffe Hospital), Graeme Alexander(Addenbrooke's Hospital), Laura Griffiths(Newcastle University), Douglas Thorburn(Royal Free London NHS Foundation Trust), Richard Sandford(University of Cambridge), James Neuberger(Queen Elizabeth Hospital Birmingham)
Cited by 348
Related Papers
Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL Conference
|Journal of Hepatology|2001|4.1k
A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis
|New England Journal of Medicine|2016|1.1k